Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells.

Congenital heart defects are the most common birth defect. The limiting factor in tissue engineering repair strategies is an autologous source of functional cardiomyocytes. Amniotic fluid contains an ideal cell source for prenatal harvest and use in correction of congenital heart defects. This study...

Full description

Bibliographic Details
Main Authors: Aaron J Velasquez-Mao, Christopher J M Tsao, Madeline N Monroe, Xavier Legras, Beatrice Bissig-Choisat, Karl-Dimiter Bissig, Rodrigo Ruano, Jeffrey G Jacot
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5435315?pdf=render
_version_ 1828970673506091008
author Aaron J Velasquez-Mao
Christopher J M Tsao
Madeline N Monroe
Xavier Legras
Beatrice Bissig-Choisat
Karl-Dimiter Bissig
Rodrigo Ruano
Jeffrey G Jacot
author_facet Aaron J Velasquez-Mao
Christopher J M Tsao
Madeline N Monroe
Xavier Legras
Beatrice Bissig-Choisat
Karl-Dimiter Bissig
Rodrigo Ruano
Jeffrey G Jacot
author_sort Aaron J Velasquez-Mao
collection DOAJ
description Congenital heart defects are the most common birth defect. The limiting factor in tissue engineering repair strategies is an autologous source of functional cardiomyocytes. Amniotic fluid contains an ideal cell source for prenatal harvest and use in correction of congenital heart defects. This study aims to investigate the potential of amniotic fluid-derived stem cells (AFSC) to undergo non-viral reprogramming into induced pluripotent stem cells (iPSC) followed by growth-factor-free differentiation into functional cardiomyocytes. AFSC from human second trimester amniotic fluid were transfected by non-viral vesicle fusion with modified mRNA of OCT4, KLF4, SOX2, LIN28, cMYC and nuclear GFP over 18 days, then differentiated using inhibitors of GSK3 followed 48 hours later by inhibition of WNT. AFSC-derived iPSC had high expression of OCT4, NANOG, TRA-1-60, and TRA-1-81 after 18 days of mRNA transfection and formed teratomas containing mesodermal, ectodermal, and endodermal germ layers in immunodeficient mice. By Day 30 of cardiomyocyte differentiation, cells contracted spontaneously, expressed connexin 43 and β-myosin heavy chain organized in sarcomeric banding patterns, expressed cardiac troponin T and β-myosin heavy chain, showed upregulation of NKX2.5, ISL-1 and cardiac troponin T with downregulation of POU5F1, and displayed calcium and voltage transients similar to those in developing cardiomyocytes. These results demonstrate that cells from human amniotic fluid can be differentiated through a pluripotent state into functional cardiomyocytes.
first_indexed 2024-12-14T12:55:06Z
format Article
id doaj.art-5cb05578bf824691b6a7a9d7f139f17a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T12:55:06Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-5cb05578bf824691b6a7a9d7f139f17a2022-12-21T23:00:35ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01125e017782410.1371/journal.pone.0177824Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells.Aaron J Velasquez-MaoChristopher J M TsaoMadeline N MonroeXavier LegrasBeatrice Bissig-ChoisatKarl-Dimiter BissigRodrigo RuanoJeffrey G JacotCongenital heart defects are the most common birth defect. The limiting factor in tissue engineering repair strategies is an autologous source of functional cardiomyocytes. Amniotic fluid contains an ideal cell source for prenatal harvest and use in correction of congenital heart defects. This study aims to investigate the potential of amniotic fluid-derived stem cells (AFSC) to undergo non-viral reprogramming into induced pluripotent stem cells (iPSC) followed by growth-factor-free differentiation into functional cardiomyocytes. AFSC from human second trimester amniotic fluid were transfected by non-viral vesicle fusion with modified mRNA of OCT4, KLF4, SOX2, LIN28, cMYC and nuclear GFP over 18 days, then differentiated using inhibitors of GSK3 followed 48 hours later by inhibition of WNT. AFSC-derived iPSC had high expression of OCT4, NANOG, TRA-1-60, and TRA-1-81 after 18 days of mRNA transfection and formed teratomas containing mesodermal, ectodermal, and endodermal germ layers in immunodeficient mice. By Day 30 of cardiomyocyte differentiation, cells contracted spontaneously, expressed connexin 43 and β-myosin heavy chain organized in sarcomeric banding patterns, expressed cardiac troponin T and β-myosin heavy chain, showed upregulation of NKX2.5, ISL-1 and cardiac troponin T with downregulation of POU5F1, and displayed calcium and voltage transients similar to those in developing cardiomyocytes. These results demonstrate that cells from human amniotic fluid can be differentiated through a pluripotent state into functional cardiomyocytes.http://europepmc.org/articles/PMC5435315?pdf=render
spellingShingle Aaron J Velasquez-Mao
Christopher J M Tsao
Madeline N Monroe
Xavier Legras
Beatrice Bissig-Choisat
Karl-Dimiter Bissig
Rodrigo Ruano
Jeffrey G Jacot
Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells.
PLoS ONE
title Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells.
title_full Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells.
title_fullStr Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells.
title_full_unstemmed Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells.
title_short Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells.
title_sort differentiation of spontaneously contracting cardiomyocytes from non virally reprogrammed human amniotic fluid stem cells
url http://europepmc.org/articles/PMC5435315?pdf=render
work_keys_str_mv AT aaronjvelasquezmao differentiationofspontaneouslycontractingcardiomyocytesfromnonvirallyreprogrammedhumanamnioticfluidstemcells
AT christopherjmtsao differentiationofspontaneouslycontractingcardiomyocytesfromnonvirallyreprogrammedhumanamnioticfluidstemcells
AT madelinenmonroe differentiationofspontaneouslycontractingcardiomyocytesfromnonvirallyreprogrammedhumanamnioticfluidstemcells
AT xavierlegras differentiationofspontaneouslycontractingcardiomyocytesfromnonvirallyreprogrammedhumanamnioticfluidstemcells
AT beatricebissigchoisat differentiationofspontaneouslycontractingcardiomyocytesfromnonvirallyreprogrammedhumanamnioticfluidstemcells
AT karldimiterbissig differentiationofspontaneouslycontractingcardiomyocytesfromnonvirallyreprogrammedhumanamnioticfluidstemcells
AT rodrigoruano differentiationofspontaneouslycontractingcardiomyocytesfromnonvirallyreprogrammedhumanamnioticfluidstemcells
AT jeffreygjacot differentiationofspontaneouslycontractingcardiomyocytesfromnonvirallyreprogrammedhumanamnioticfluidstemcells